Donna Ambrosino
Director/Board Member at CLOVER BIOPHARMACEUTICALS, LTD.
Net worth: 7 039 $ as of 2024-04-29
Donna Ambrosino active positions
| Companies | Position | Start | End |
|---|---|---|---|
| CLOVER BIOPHARMACEUTICALS, LTD. | Director/Board Member | 2022-06-16 | - |
Career history of Donna Ambrosino
Former positions of Donna Ambrosino
| Companies | Position | Start | End |
|---|---|---|---|
| VISTERRA INC | Chief Tech/Sci/R&D Officer | 2011-12-31 | 2013-12-31 |
| Harvard Medical School | Corporate Officer/Principal | - | - |
Training of Donna Ambrosino
| Dartmouth Medical School | Doctorate Degree |
| Harvard University | Undergraduate Degree |
Statistics
International
| United States | 5 |
| China | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Consumer Services | 4 |
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| CLOVER BIOPHARMACEUTICALS, LTD. | Health Technology |
| Private companies | 1 |
|---|---|
Visterra, Inc.
 Visterra, Inc. Pharmaceuticals: MajorHealth Technology Visterra, Inc. Is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of antibody-based therapies for kidney diseases, and other chronic diseases. It focuses on its research technology platform, HIEROTOPE technology. The company was founded by Alan L. Crane, Kevin J. Bitterman and Ram Sasisekharan on December 20, 2007 and is headquartered in Waltham, MA. | Health Technology |
- Stock Market
- Insiders
- Donna Ambrosino
- Experience
